SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Evaluation of Screened Blood Donations for Human Immunodeficiency Virus Type 1 Infection by Culture and DNA Amplification of Pooled Cells
4 references·16 citing·28 second hop
Evaluation of Screened Blood Donations for Human Immunodeficiency Virus Type 1 Infection by Culture and DNA Amplification of Pooled Cells (1991)Evaluation of Screened Blood Donations fo…Risk of human immunodeficiency virus (HIV) transmission by blood transfusions before the implementation of HIV‐1 antibody screening (1991)Risk of human immunodeficienc…Transmission of Retroviruses by Transfusion of Screened Blood in Patients Undergoing Cardiac Surgery (1989)Transmission of Retroviruses …Exposure of Patients to Human Immunodeficiency Virus through the Transfusion of Blood Components That Test Antibody-Negative (1989)Exposure of Patients to Human…Transmission of Human Immunodeficiency Virus (HIV) by Blood Transfusions Screened as Negative for HIV Antibody (1988)Transmission of Human Immunod…SEROPREVALENCE OF CYTOMEGALOVIRUS, HEPATITIS B, HEPATITIS C AND HUMAN IMMUNODEFICIENCY VIRUS ANTIBODIES AMONG VOLUNTEER BLOOD DONORS (2004)SEROPREVALENCE OF CYTOMEGALOV…Évaluation du risque infectieux résiduel chez les donneurs de sang au Centre national de transfusion sanguine de Conakry (2004)Évaluation du risque infectie…The risks of transfusion-transmitted infection: direct estimation and mathematical modelling (2000)The risks of transfusion-tran…Current viral risks of blood and blood products (2000)Current viral risks of blood …The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection (1997)The incidence/window period m…Infectious risk of plasma donations: relationship to safety of intravenous immune globulins (1996)Infectious risk of plasma don…Estimation du risque de transmission des virus des hépatites B et C et des rétrovirus humains par transfusion de dérivés sanguins labiles (1996)Estimation du risque de trans…Safety of the Blood Supply (1995)Safety of the Blood SupplyThe effectiveness of the confidential unit exclusion option (1994)The effectiveness of the conf…HIV AND BLOOD TRANSFUSIONS: FOCUS ON SEROCONVERSION (1994)HIV AND BLOOD TRANSFUSIONS: F…Direct oral questions to blood donors: the impact on screening for human immunodeficiency virus (1994)Direct oral questions to bloo…An optimal design of cumulative sum control chart based on median run length (1994)An optimal design of cumulati…The Nation's Changing Blood Supply System (1993)The Nation's Changing Blood S…Transmission of Retroviruses from Seronegative Donors by Transfusion during Cardiac Surgery (1992)Transmission of Retroviruses …Risk of HIV infection from transfusion with blood negative for HIV antibody in a west African city. (1992)Risk of HIV infection from tr…Safety of blood donations following a natural disaster (1991)Safety of blood donations fol…Collection and Transfusion of Blood in the United States, 1982–1988 (1990)The Risk of Transfusion-Transmitted Infection (1992)Safety of the Blood Supply (1998)An estimate of the current risk of transmitting blood‐borne infections through blood transfusion in Italy (2002)Where have all the donors gone? A personal reflection on the crisis in America's volunteer blood program (2003)Estimated Risk of Transmission of the Human Immunodeficiency Virus by Screened Blood in the United States (1995)The Risk of Transfusion-Transmitted Viral Infections (1996)Reduced frequency of blood donors with false‐positive HIV‐1 and ‐2 antibody EIA reactivity after elution of low‐affinity nonspecific natural antibodies (2002)Impact of changes in viral marker screening assays (2003)Can the nucleic acid amplification test (NAT) be an alternative to the serologic tests? A prospective study, the results of 18,200 blood donors from the Turkish Red Crescent (2010)Reporting on Methods in Clinical Trials (1982)Trends in Incidence and Prevalence of Major Transfusion-Transmissible Viral Infections in US Blood Donors, 1991 to 1996 (2000)Health and economic impact of posttransfusion hepatitis B and cost‐effectiveness analysis of expanded HBV testing protocols of blood donors: a study focused on the European Union (2003)Transfusion risks of yesterday and of today (2003)Residual infectious disease risk in screened blood transfusion from a high‐prevalence population: Santa Catarina, Brazil (2007)Antibody to Hepatitis B Core Antigen as a Paradoxical Marker for Non-A, Non-B Hepatitis Agents in Donated Blood (1986)Results of Viral Marker Screening of Unpaid Blood Donations and Probability of Window Period Donations in 1997 (2000)Results of Viral Marker Screening of Unpaid Blood Donations and Probability of Window Period Donations in 1997 (2000)Bloodborne infections among student voluntary blood donors in Mansoura University, Egypt. (2006)Cost‐effectiveness of expanded human immunodeficiency virus‐testing protocols for donated blood (1997)Seroprevalence of hepatitis B, C and HIV in blood donors in northern Pakistan. (2002)Hepatitis B, hepatitis C and HIV transfusion‐transmitted infections in the 21st century (2010)Prevalence of Human Immunodeficiency Virus Type 1 p24 Antigen in U.S. Blood Donors — An Assessment of the Efficacy of Testing in Donor Screening (1990)International application of the Incidence Rate/Window Period model (2002)Cost‐effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States (2004)Current incidence and estimated residual risk of transfusion‐transmitted infections in donations made to Canadian Blood Services (2007)The Retrovirus Epidemiology Donor Study (REDS): rationale and methods (1995)Computer-Based Interview for Screening Blood Donors for Risk of HIV Transmission (1992)
this work references cited by second hop

References

  • 1988Transmission of Human Immunodeficiency Virus (HIV) by Blood Transfusions Screened as Negative for HIV Antibody467 cited
  • 1989Exposure of Patients to Human Immunodeficiency Virus through the Transfusion of Blood Components That Test Antibody-Negative244 cited
  • 1989Transmission of Retroviruses by Transfusion of Screened Blood in Patients Undergoing Cardiac Surgery178 cited
  • 1991Risk of human immunodeficiency virus (HIV) transmission by blood transfusions before the implementation of HIV‐1 antibody screening177 cited

Cited by

  • 1997The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection168 cited
  • 1992Transmission of Retroviruses from Seronegative Donors by Transfusion during Cardiac Surgery102 cited
  • 1995Safety of the Blood Supply100 cited
  • 1993The Nation's Changing Blood Supply System98 cited
  • 2000Current viral risks of blood and blood products64 cited
  • 2000The risks of transfusion-transmitted infection: direct estimation and mathematical modelling63 cited
  • 1994The effectiveness of the confidential unit exclusion option56 cited
  • 1994An optimal design of cumulative sum control chart based on median run length52 cited
  • 1991Safety of blood donations following a natural disaster46 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

1992
Risk of HIV infection from transfusion with blood negative for HIV antibody in a west African city.
43 cited
  • 2004Évaluation du risque infectieux résiduel chez les donneurs de sang au Centre national de transfusion sanguine de Conakry36 cited
  • 1994Direct oral questions to blood donors: the impact on screening for human immunodeficiency virus31 cited
  • 1994HIV AND BLOOD TRANSFUSIONS: FOCUS ON SEROCONVERSION29 cited
  • 1996Estimation du risque de transmission des virus des hépatites B et C et des rétrovirus humains par transfusion de dérivés sanguins labiles27 cited
  • 1996Infectious risk of plasma donations: relationship to safety of intravenous immune globulins27 cited
  • 2004SEROPREVALENCE OF CYTOMEGALOVIRUS, HEPATITIS B, HEPATITIS C AND HUMAN IMMUNODEFICIENCY VIRUS ANTIBODIES AMONG VOLUNTEER BLOOD DONORS25 cited